The extended list of FOXA2 targets (92) contains high overexpression of the “molecular transporter” category, further supporting the phenotype that FOXA2 deficiency leads to reduced bile acid transporter expression and cholestasis. The gene discussed is FOXA2; the disease is cholestasis.